Pyruvate dehydrogenase

Class

Pyruvate dehydrogenase activator (metabolic modulator)

Pyruvate dehydrogenase (PDH) is a large mitochondrial enzyme complex that converts pyruvate, the end-product of glycolysis, into acetyl-coenzyme A, the molecule that feeds into the citric acid (Krebs) cycle for oxidative energy production. It sits at the gatekeeper step between glucose breakdown in the cytoplasm and full oxidative metabolism inside mitochondria. The complex is normally kept partially inactive by a regulatory enzyme, pyruvate dehydrogenase kinase, which phosphorylates and inhibits it, favoring fat oxidation and lactate production over glucose oxidation. Pharmacological activators of PDH aim to shift this balance toward glucose oxidation by preventing or reversing that inhibitory phosphorylation. The biological rationale is that many metabolic and ischemic conditions feature impaired glucose oxidation and excess reliance on glycolysis, leading to lactate accumulation, poor cellular energy efficiency, or insulin resistance. Restoring PDH activity can improve glucose disposal and reduce lactate buildup, making this mechanism of interest in disorders of glucose metabolism such as type 2 diabetes, in certain inherited metabolic diseases affecting energy production, and in conditions of tissue ischemia where oxidative fuel use becomes compromised. Because PDH activity is central to whole-body fuel selection, drugs targeting it are studied for their broad metabolic effects rather than a single organ-specific action.